Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.016 0.002 (14.29%) Market Cap: 993,000.00 Enterprise Value: 43.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Evofem Biosciences Inc Investor Call Transcript

Aug 11, 2022 / 09:00PM GMT
Release Date Price: $57.49 (-3.83%)
Operator

Good afternoon and welcome to the Evofem Biosciences investor update call. I'll turn the call over to Amy Raskopf, Evofem Biosciences' Vice President of Investor Relations.

Amy Raskopf
Evofem Biosciences, Inc. - VP of IR

Thank you all for joining us this afternoon. Before we begin, I would like to remind you that remarks on this call will contain forward-looking statements, which are made only as of today, August 11, 2022. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10-Q.

With that, I'll turn the call over to Evofem's CEO, Saundra Pelletier.

Saundra Pelletier
Evofem Biosciences, Inc. - Interim Chair, President & CEO

Thank you for joining the call today. The purpose of the call is to provide clarity on the listing of Evofem's common stock and our future plans. On Tuesday afternoon, we were notified at the Nasdaq Hearings Panel's decision to delist our shares

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot